US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 31.510
  • -0.850-2.63%
Close Jun 14 16:00 ET
  • 31.280
  • -0.230-0.73%
Post 16:23 ET
1.60BMarket Cap-693P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-61.96%886K
0
0
10.08%688K
-85.46%198K
-87.57%2.33M
-95.39%168K
-87.56%174K
-95.44%625K
Operating revenue
--0
-61.96%886K
--0
--0
10.08%688K
-85.46%198K
-87.57%2.33M
-95.39%168K
-87.56%174K
-95.44%625K
Cost of revenue
Gross profit
Operating expense
151.39%47.77M
48.61%129.45M
147.05%47.75M
75.62%33.24M
27.77%29.45M
-26.35%19M
3.23%87.11M
-19.75%19.33M
-12.74%18.93M
12.97%23.05M
Selling and administrative expenses
145.72%12.85M
40.01%39.95M
177.06%14.07M
23.48%8.58M
57.16%12.06M
-40.76%5.23M
4.44%28.53M
-30.46%5.08M
1.65%6.95M
12.50%7.68M
-General and administrative expense
145.72%12.85M
40.01%39.95M
177.06%14.07M
23.48%8.58M
57.16%12.06M
-40.76%5.23M
4.44%28.53M
-30.46%5.08M
1.65%6.95M
12.50%7.68M
Research and development costs
153.54%34.93M
52.79%89.5M
136.35%33.68M
105.89%24.66M
13.09%17.39M
-18.86%13.78M
2.65%58.58M
-15.08%14.25M
-19.36%11.98M
13.21%15.37M
Operating profit
-154.04%-47.77M
-51.64%-128.56M
-149.21%-47.75M
-77.25%-33.24M
-28.26%-28.76M
23.06%-18.81M
-29.14%-84.78M
6.26%-19.16M
7.58%-18.76M
-234.42%-22.42M
Net non-operating interest income expense
955.24%4.43M
634.41%6.15M
906.34%4.13M
334.38%1.25M
236.54%350K
1,100.00%420K
654.05%837K
1,105.88%410K
700.00%288K
447.37%104K
Non-operating interest income
955.24%4.43M
634.41%6.15M
906.34%4.13M
334.38%1.25M
236.54%350K
1,100.00%420K
654.05%837K
1,105.88%410K
700.00%288K
447.37%104K
Other net income (expense)
-570.83%-483K
-3,091,314.29%-216.4M
-61,000.00%-19.55M
-33,895.83%-8.11M
-3,773,380.00%-188.66M
-140.00%-72K
94.26%-7K
-113.33%-32K
200.00%24K
109.62%5K
Gain on sale of security
----
---83.53M
--0
---25.36M
---58.17M
----
----
----
----
----
Special income (charges)
----
---113.74M
--1.84M
--14.91M
---130.49M
----
--0
--0
--0
--0
-Less:Other special charges
----
--113.74M
---1.84M
---14.91M
--130.49M
----
----
----
----
----
Other non- operating income (expenses)
-570.83%-483K
-273,185.71%-19.13M
-66,750.00%-21.39M
9,658.33%2.34M
-260.00%-8K
-140.00%-72K
94.26%-7K
-113.33%-32K
200.00%24K
109.62%5K
Income before tax
-137.43%-43.83M
-303.59%-338.82M
-236.35%-63.18M
-117.45%-40.1M
-872.82%-217.07M
24.46%-18.46M
-27.86%-83.95M
8.03%-18.78M
9.06%-18.44M
-231.17%-22.31M
Income tax
188.89%32K
80.88%-26K
0
101.44%3K
-22.22%7K
-36K
-196.45%-136K
65.22%38K
-903.85%-209K
-90.22%9K
Net income
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
Net income continuous Operations
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
Minority interest income
Net income attributable to the parent company
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-138.07%-43.86M
-304.21%-338.79M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
-27.38%-83.82M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
Basic earnings per share
75.46%-1.2
-97.59%-49.12
62.64%-1.7522
-92.98%-9.34
-740.74%-56.75
47.14%-4.89
0.64%-24.86
39.64%-4.69
37.55%-4.84
-170.00%-6.75
Diluted earnings per share
75.46%-1.2
-97.59%-49.12
62.64%-1.7522
-92.98%-9.34
-740.74%-56.75
47.14%-4.89
0.64%-24.86
39.64%-4.69
37.55%-4.84
-170.00%-6.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-61.96%886K0010.08%688K-85.46%198K-87.57%2.33M-95.39%168K-87.56%174K-95.44%625K
Operating revenue --0-61.96%886K--0--010.08%688K-85.46%198K-87.57%2.33M-95.39%168K-87.56%174K-95.44%625K
Cost of revenue
Gross profit
Operating expense 151.39%47.77M48.61%129.45M147.05%47.75M75.62%33.24M27.77%29.45M-26.35%19M3.23%87.11M-19.75%19.33M-12.74%18.93M12.97%23.05M
Selling and administrative expenses 145.72%12.85M40.01%39.95M177.06%14.07M23.48%8.58M57.16%12.06M-40.76%5.23M4.44%28.53M-30.46%5.08M1.65%6.95M12.50%7.68M
-General and administrative expense 145.72%12.85M40.01%39.95M177.06%14.07M23.48%8.58M57.16%12.06M-40.76%5.23M4.44%28.53M-30.46%5.08M1.65%6.95M12.50%7.68M
Research and development costs 153.54%34.93M52.79%89.5M136.35%33.68M105.89%24.66M13.09%17.39M-18.86%13.78M2.65%58.58M-15.08%14.25M-19.36%11.98M13.21%15.37M
Operating profit -154.04%-47.77M-51.64%-128.56M-149.21%-47.75M-77.25%-33.24M-28.26%-28.76M23.06%-18.81M-29.14%-84.78M6.26%-19.16M7.58%-18.76M-234.42%-22.42M
Net non-operating interest income expense 955.24%4.43M634.41%6.15M906.34%4.13M334.38%1.25M236.54%350K1,100.00%420K654.05%837K1,105.88%410K700.00%288K447.37%104K
Non-operating interest income 955.24%4.43M634.41%6.15M906.34%4.13M334.38%1.25M236.54%350K1,100.00%420K654.05%837K1,105.88%410K700.00%288K447.37%104K
Other net income (expense) -570.83%-483K-3,091,314.29%-216.4M-61,000.00%-19.55M-33,895.83%-8.11M-3,773,380.00%-188.66M-140.00%-72K94.26%-7K-113.33%-32K200.00%24K109.62%5K
Gain on sale of security -------83.53M--0---25.36M---58.17M--------------------
Special income (charges) -------113.74M--1.84M--14.91M---130.49M------0--0--0--0
-Less:Other special charges ------113.74M---1.84M---14.91M--130.49M--------------------
Other non- operating income (expenses) -570.83%-483K-273,185.71%-19.13M-66,750.00%-21.39M9,658.33%2.34M-260.00%-8K-140.00%-72K94.26%-7K-113.33%-32K200.00%24K109.62%5K
Income before tax -137.43%-43.83M-303.59%-338.82M-236.35%-63.18M-117.45%-40.1M-872.82%-217.07M24.46%-18.46M-27.86%-83.95M8.03%-18.78M9.06%-18.44M-231.17%-22.31M
Income tax 188.89%32K80.88%-26K0101.44%3K-22.22%7K-36K-196.45%-136K65.22%38K-903.85%-209K-90.22%9K
Net income -138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M10.21%-18.23M-226.84%-22.32M
Net income continuous Operations -138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M10.21%-18.23M-226.84%-22.32M
Minority interest income
Net income attributable to the parent company -138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M10.21%-18.23M-226.84%-22.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -138.07%-43.86M-304.21%-338.79M-235.67%-63.18M-119.96%-40.11M-872.45%-217.08M24.61%-18.42M-27.38%-83.82M7.94%-18.82M10.21%-18.23M-226.84%-22.32M
Basic earnings per share 75.46%-1.2-97.59%-49.1262.64%-1.7522-92.98%-9.34-740.74%-56.7547.14%-4.890.64%-24.8639.64%-4.6937.55%-4.84-170.00%-6.75
Diluted earnings per share 75.46%-1.2-97.59%-49.1262.64%-1.7522-92.98%-9.34-740.74%-56.7547.14%-4.890.64%-24.8639.64%-4.6937.55%-4.84-170.00%-6.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg